Press Releases

January 23 2014

BIO announced plenary sessions, Business Roundtables and Therapeutic Workshops selected for the...

November 13 2013

The Bill will spur capital formation for small public companies

September 30 2013

NSF-funded companies focused on drug discovery, diagnostics and other platform technologies....

September 11 2013

Speakers will provide fresh insight, investment opportunities in biotech sector.

July 10 2013

Chimerix President and CEO emphasizes the role of the public market to help finance critical R...

April 16 2013

Bill would allow emerging biotech companies to maintain a working relationship with their...

January 23 2013

Ken Lisaius has been named Vice President of Communications at BIO.

February 15 2012

The bill will modernize the FDA and accelerate patient access to cures and new treatments.

December 16 2011

Grants will provide critical funding to small emerging biotechnology companies working on...

December 13 2011

Small Business Innovation Research (SBIR) grants provide critical funding for the development...

November 22 2011

BIO CEO & Investor Conference will be held February 13 – 14 in New York City, NY...

November 16 2011

"The most important return on investment from this initiative would be the creation of...

September 16 2011

BIO President and CEO Jim Greenwood released the following statement on President Obama's...

September 6 2011

The Biotechnology Industry Organization (BIO) today announces the initial selection of...

May 4 2011

BIO announces selection of Congressman Fred Upton (R-MI) as Legislator of the Year for 2010 -...

May 4 2011

BIO announced today its selection of Senator Bob Casey (D-PA) as Legislator of the Year for...

May 4 2011

BIO announces its selection of Representative David E. Price (D-NC) as Legislator of the Year...

May 4 2011

BIO announces its selection of Michael Capuano (D-MA) as Legislator of the Year for 2010 -...

May 3 2011

BIO announces its selection of Senator Patrick Leahy (D-VT) as Legislator of the Year for 2010...

April 7 2011

Today, the House Subcommittee on Healthcare and Technology will hold a hearing on The Creating...

March 3 2011

The Virginia Refundable Research and Development Tax Credit, recently passed by the Virginia...

July 30 2008

Small businesses that are majority-backed by venture capital, many of which are producing...

September 13 2011
These written comments were submitted to accompany the testimony of BIO's Interim Vice President for State Government Relations Pete Pellerito in support of legislative and regulatory environments that benefit biosciences industry job growth.
April 7 2011
The House Subcommittee on Healthcare and Technology held a hearing on The Creating Jobs Through Small Business Innovation Act of 2011, a bill that would reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which help fund small innovative companies on the brink of new technologies and discoveries.
March 24 2011
BIO submitted letters of support for the American Research and Competitiveness Act of 2011 (HR 942) to the lead House of Representatives sponsors.
November 1 2009
BIO is submitting this letter in response to the request by the United States Trade Representative (USTR) for comments to compile the National Trade Estimate (NTE) Report on Foreign Trade Barriers.
November 15 2008
BIO urges that changes to FIN46(R) accurately reflect the underlying economics of collaborations.
April 9 2014
The House Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing titled “Legislative Proposals to Enhance Capital Formation for Small and Emerging Growth Companies.” Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc. presented testimony at the hearing on enhancements to the capital markets that can increase access to investors and decrease unnecessary regulatory burdens for emerging biotech companies trading on the public market.
January 23 2014
BIO announced plenary sessions, Business Roundtables and Therapeutic Workshops selected for the 16th annual BIO CEO & Investor Conference.
November 13 2013
The Bill will spur capital formation for small public companies
September 30 2013
NSF-funded companies focused on drug discovery, diagnostics and other platform technologies.
September 11 2013
Speakers will provide fresh insight, investment opportunities in biotech sector.